![Rainer Boehm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rainer Boehm
Direttore/Membro del Consiglio presso
OMEA THER
Patrimonio netto: - $ in data 30/09/2026
Profilo
Rainer J.
Boehm is the founder of Rainer Boehm GmbH.
Current jobs include Chairman at Berlin Cures Holding AG since 2022, Independent Director at Omega Therapeutics, Inc. since 2022, and Director at BioCopy AG since 2020.
Former jobs include Chief Executive Officer & Head-Pharma Division at Novartis Pharma SAS, Independent Director at Nordic Nanovector ASA from 2018 to 2022, Independent Director at Humanigen, Inc. from 2018 to 2024, Independent Director at Cellectis SA from 2017 to 2026, Executive Vice President-North America at Novartis Oncology, Inc. from 2005 to 2010, and Chief Commercial & Medical Affairs Officer at Novartis Pharma Schweiz AG from 2010 to 2017.
Education includes a doctorate from Universität Ulm and an MBA from Schiller International University (France).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CELLECTIS S.A. -.--% | 15/02/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Posizioni attive di Rainer Boehm
| Società | Posizione | Inizio |
|---|---|---|
| OMEA THER | Direttore/Membro del Consiglio | 01/09/2022 |
Rainer Boehm GmbH | Fondatore | - |
BioCopy AG
 BioCopy AG BiotechnologyHealth Technology Discovers and develops biotherapeutic drugs using an automated, AI-assisted end-to-end platform | Direttore/Membro del Consiglio | 01/02/2020 |
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Presidente | - |
Precedenti posizioni note di Rainer Boehm
| Società | Posizione | Fine |
|---|---|---|
| CELLECTIS S.A. | Direttore/Membro del Consiglio | 25/06/2026 |
| HUMANIGEN, INC. | Direttore/Membro del Consiglio | 01/02/2024 |
| THOR MEDICAL | Direttore/Membro del Consiglio | 28/04/2022 |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/01/2010 |
Formazione di Rainer Boehm
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
63
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Universität Ulm
 Universität Ulm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Schiller International University (France)
 Schiller International University (France) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Health Technology |
Rainer Boehm GmbH | |
BioCopy AG
BioCopy AG BiotechnologyHealth Technology Discovers and develops biotherapeutic drugs using an automated, AI-assisted end-to-end platform | Health Technology |
